Research on Cognitive Function in Anxious Depression Patients in China.

[1]  Lisanne M. Jenkins,et al.  Differential engagement of cognitive control regions and subgenual cingulate based upon presence or absence of comorbid anxiety with depression. , 2018, Journal of affective disorders.

[2]  Zhijun Zhang,et al.  Amygdala connectivity mediates the association between anxiety and depression in patients with major depressive disorder , 2018, Brain Imaging and Behavior.

[3]  R. Lam,et al.  Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management. , 2017, The Journal of clinical psychiatry.

[4]  M. Zimmerman,et al.  Measuring anxiety in depressed patients: A comparison of the Hamilton anxiety rating scale and the DSM-5 Anxious Distress Specifier Interview. , 2017, Journal of psychiatric research.

[5]  G. Dawson,et al.  Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls , 2017, Molecular Psychiatry.

[6]  L. Williams,et al.  Defining biotypes for depression and anxiety based on large‐scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation , 2017, Depression and anxiety.

[7]  D. Noll,et al.  Comorbid anxiety increases cognitive control activation in Major Depressive Disorder , 2016, Depression and anxiety.

[8]  T. Si,et al.  The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol , 2016, BMC Psychiatry.

[9]  Y. Torres,et al.  Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys , 2015, Epidemiology and Psychiatric Sciences.

[10]  D. Goldberg.  ANXIOUS FORMS OF DEPRESSION , 2014, Depression and anxiety.

[11]  Peter de Jonge,et al.  Gender differences in major depressive disorder: results from the Netherlands study of depression and anxiety. , 2014, Journal of affective disorders.

[12]  D. Ionescu,et al.  NEUROBIOLOGY OF ANXIOUS DEPRESSION: A REVIEW , 2013, Depression and anxiety.

[13]  J. Guelfi,et al.  Assessment of Anxiety in Clinical Trials with Depressed Patients Using the Hamilton Depression Rating Scale. , 2011, Psychopharmacology bulletin.

[14]  P. DeRosse,et al.  The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder , 2011, Neuropsychopharmacology.

[15]  H. Seo,et al.  Distinctive Clinical Characteristics and Suicidal Tendencies of Patients With Anxious Depression , 2011, The Journal of nervous and mental disease.

[16]  Jürgen Kayser,et al.  EEG Hemispheric Asymmetries during Cognitive Tasks in Depressed Patients with High versus Low Trait Anxiety , 2010, Clinical EEG and neuroscience.

[17]  A. Vaccarino,et al.  Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression , 2008, Depression and anxiety.

[18]  Maurizio Fava,et al.  Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. , 2008, The American journal of psychiatry.

[19]  T. Mclaughlin,et al.  Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization. , 2006, The Journal of clinical psychiatry.

[20]  R. de Graaf,et al.  Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. , 2005, Archives of general psychiatry.

[21]  P. Llorca,et al.  Efficacy of escitalopram in patients with severe depression: a pooled analysis , 2005, International journal of clinical practice.

[22]  M. Fava,et al.  Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D , 2004, Psychological Medicine.

[23]  Matthias J. Müller,et al.  Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) in psychiatric novices. , 2003, Journal of affective disorders.

[24]  D. Kupfer,et al.  Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. , 2003, The Psychiatric clinics of North America.

[25]  R. Hirschfeld,et al.  The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care. , 2001, Primary care companion to the Journal of clinical psychiatry.

[26]  R. Kessler,et al.  Comorbidity of DSM–III–R Major Depressive Disorder in the General Population: Results from the US National Comorbidity Survey , 1996, British Journal of Psychiatry.

[27]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[28]  G. H. Savage.  Constant Watching of Suicidal Cases , 1884 .

[29]  Femke Lamers,et al.  Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome , 2018, Current opinion in psychiatry.

[30]  M. Tausig.  Work and Mental Health , 1999 .

[31]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[32]  I. Heuser,et al.  The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. , 1988, Journal of affective disorders.

[33]  C. Shagass.  Possible contributions of evoked potentials to the vulnerability hypothesis. , 1979, Psychopharmacology bulletin.